Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;89(1):102-104.
doi: 10.1016/j.rhum.2021.07.007. Epub 2021 Jul 27.

Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)

[Article in French]
Affiliations

Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)

[Article in French]
Baptiste Queré et al. Rev Rhum Ed Fr. 2022 Jan.
No abstract available

PubMed Disclaimer

References

    1. Giollo A., Adami G., Gatti D., Idolazzi L., Rossini M. Coronavirus disease 19 (COVID-19) and non-steroidal anti-inflammatory drugs (NSAID) Ann Rheum Dis. 2020 doi: 10.1136/annrheumdis-2020-217598. - DOI - PubMed
    1. FitzGerald G.A. Misguided drug advice for COVID-19. Science. 2020;367:1434. doi: 10.1126/science.abb8034. - DOI - PubMed
    1. Richez C., Flipo R.-M., Berenbaum F., Cantagrel A., Claudepierre P., Debiais F., et al. Managing patients with rheumatic diseases during the COVID-19 pandemic: the French Society of Rheumatology answers to most frequently asked questions up to May 2020. Joint Bone Spine. 2020;87:431–437. doi: 10.1016/j.jbspin.2020.05.006. - DOI - PMC - PubMed
    1. Francesconi P., Cantini F., Profili F., Mannoni A., Bellini B., Benucci M. COVID-19 epidemiology in rheumatic diseases in Tuscany: a case-control study. Joint Bone Spine. 2021;88:105131. - PMC - PubMed
    1. Quartuccio L., Valent F., Pasut E., Tascini C., De Vita S. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine. 2020;87:439–443. - PMC - PubMed

LinkOut - more resources